Douglas D. Burkett

Nessuna posizione attualmente

60 anni

Consumer Services

Health Technology

Profilo

Douglas D.
Burkett served as Chairman, President & Chief Executive Officer at Zila, Inc. from 2002 to 2007.
He also served as President & Chief Executive Officer at Champions Oncology, Inc. in 2009.
Burkett earned a doctorate degree from Arizona State University in 1994 and an undergraduate degree from Missouri Western State College in 1987.

Precedenti posizioni note di Douglas D. Burkett

Società	Posizione	Fine
CHAMPIONS ONCOLOGY, INC.	Presidente	31/12/2009
Zila, Inc. Zila, Inc. Medical SpecialtiesHealth Technology Zila, Inc., headquartered in Scottsdale, Arizona and founded in 1988, is a diagnostic company that offers prevention, detection and treatment of oral cancer and periodontal disease. Zila manufactures and markets ViziLite Plus with TBlue (“ViziLite Plus”), the company’s product for the detection of oral abnormalities that could lead to cancer. ViziLite Plus is a medical device for use in a popilation risking for oral cancer. Zila designs, manufactures and markets products sold directly to dental professionals for periodontal disease, including the Rotadent Professional Powered Brush, the Pro-Select Platinum ultrasonic scaler and oral pharmaceutical products for both in-office and home-care use	Amministratore Delegato	13/06/2007

Vedi nel dettaglio l'esperienza di Douglas D. Burkett

Formazione di Douglas D. Burkett

Missouri Western State College	Undergraduate Degree
Arizona State University	Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Douglas D. Burkett

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
CHAMPIONS ONCOLOGY, INC.	Health Technology

Aziende private	1
Zila, Inc. Zila, Inc. Medical SpecialtiesHealth Technology Zila, Inc., headquartered in Scottsdale, Arizona and founded in 1988, is a diagnostic company that offers prevention, detection and treatment of oral cancer and periodontal disease. Zila manufactures and markets ViziLite Plus with TBlue (“ViziLite Plus”), the company’s product for the detection of oral abnormalities that could lead to cancer. ViziLite Plus is a medical device for use in a popilation risking for oral cancer. Zila designs, manufactures and markets products sold directly to dental professionals for periodontal disease, including the Rotadent Professional Powered Brush, the Pro-Select Platinum ultrasonic scaler and oral pharmaceutical products for both in-office and home-care use	Health Technology